Advertisement

video platformvideo managementvideo solutionsvideo player

The Food and Drug Administration has approved a phase 1 clinical trial to evaluate the safety of transplanting human Schwann cells to treat patients with paralysis. It is the first such trial in the world.

Advertisement
Advertisement